People | December 04, 2025
Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
New biotechnology product aims to be world's fastest automatic sanitary solution
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
Subscribe To Our Newsletter & Stay Updated
